Linda M. Distlerath

Purification and characterization of the human liver cytochromes P-450 involved in debrisoquine 4-hydroxylation and phenacetin O-deethylation, two prototypes for genetic polymorphism in oxidative drug metabolism.

Linda M. Distlerath, P.E.B. Reilly, M V Martin et al. · Journal of Biological Chemistry · 1985 · 318 citations · Full text

Medicine, Biochemistry, Pharmacology +17

Purification and characterization of the rat liver microsomal cytochrome P-450 involved in the 4-hydroxylation of debrisoquine, a prototype for genetic variation in oxidative drug metabolism

Dominique Larrey, Linda M. Distlerath, Ghazi A. Dannan et al. · Biochemistry · 1984 · 150 citations

Medicine, Biochemistry, Pharmacology +15

Substrate specificity of human liver cytochrome P-450 debrisoquine 4-hydroxylase probed using immunochemical inhibition and chemical modeling.

T. Wolff, Linda M. Distlerath, Mark Worthington et al. · PubMed · 1985 · 125 citations

Medicine, Biochemistry, Pharmacology +17

Inhibition of norfloxacin absorption by antacids

David E. Nix, John H. Wilton, B. Kuteesa Ronald et al. · Antimicrobial Agents and Chemotherapy · 1990 · 90 citations

Pharmacy, Pharmacokinetics, Pharmacology +13

Human-liver cytochromes P-450 involved in polymorphisms of drug oxidation

F. Peter Guengerich, Linda M. Distlerath, P.E.B. Reilly et al. · Xenobiotica · 1986 · 68 citations

Medicine, Biochemistry, Pharmacology +16